Non-transferable risk - Revision history

imported>Doug Williamson: Add link.

2021-07-02T19:58:32Z

Add link.

← Older revision		Revision as of 19:58, 2 July 2021
Line 12:		Line 12:
	== See also ==		== See also ==
	* [[Committed risk]]		* [[Committed risk]]
			* [[Pharmaceuticals]]
	* [[Risk management]]		* [[Risk management]]
	* [[Transferable risk]]		* [[Transferable risk]]

imported>Doug Williamson: Add link.

2020-04-19T17:48:44Z

Add link.

← Older revision		Revision as of 17:48, 19 April 2020
Line 12:		Line 12:
	== See also ==		== See also ==
	* [[Committed risk]]		* [[Committed risk]]
			* [[Risk management]]
	* [[Transferable risk]]		* [[Transferable risk]]
	* [[Uncommitted risk]]		* [[Uncommitted risk]]

imported>Doug Williamson: Classify page.

2020-04-19T17:46:48Z

Classify page.

← Older revision		Revision as of 17:46, 19 April 2020
Line 14:		Line 14:
	* [[Transferable risk]]		* [[Transferable risk]]
	* [[Uncommitted risk]]		* [[Uncommitted risk]]

			[[Category:The_business_context]]
			[[Category:Identify_and_assess_risks]]
			[[Category:Manage_risks]]
			[[Category:Risk_frameworks]]
			[[Category:Risk_reporting]]

imported>Doug Williamson: Changed firm to organisation to make article consistent

2015-05-30T08:56:08Z

Changed firm to organisation to make article consistent

← Older revision		Revision as of 08:56, 30 May 2015
Line 4:		Line 4:
	Non-transferable risks might be avoided or accepted and retained or reduced as appropriate.		Non-transferable risks might be avoided or accepted and retained or reduced as appropriate.

	In the case of non-transferable business risks (which by definition are not avoided) it is important that the ~~firm~~ has a distinctive competence in the relevant areas.		In the case of non-transferable business risks (which by definition are not avoided) it is important that the organisation has a distinctive competence in the relevant areas.

	For example, a pharmaceutical company's non-transferable risks would include the risk that failure to gain approval for use of a new drug means that the research and development costs have been wasted.		For example, a pharmaceutical company's non-transferable risks would include the risk that failure to gain approval for use of a new drug means that the research and development costs have been wasted.

imported>Doug Williamson: Layout.

2015-05-21T14:10:32Z

Layout.

← Older revision		Revision as of 14:10, 21 May 2015
Line 2:		Line 2:


	Non-transferable risks might be avoided or accepted and retained or reduced as appropriate. In the case of non-transferable business risks (which by definition are not avoided) it is important that the firm has a distinctive competence in the relevant areas.		Non-transferable risks might be avoided or accepted and retained or reduced as appropriate.

			In the case of non-transferable business risks (which by definition are not avoided) it is important that the firm has a distinctive competence in the relevant areas.

	For example, a pharmaceutical company's non-transferable risks would include the risk that failure to gain approval for use of a new drug means that the research and development costs have been wasted.		For example, a pharmaceutical company's non-transferable risks would include the risk that failure to gain approval for use of a new drug means that the research and development costs have been wasted.

imported>Doug Williamson: Link with Committed risk and Uncommitted risk pages

2015-05-20T12:11:11Z

Link with Committed risk and Uncommitted risk pages

← Older revision		Revision as of 12:11, 20 May 2015
Line 9:		Line 9:

	== See also ==		== See also ==
	*[[Transferable risk]]		* [[Committed risk]]
			* [[Transferable risk]]
			* [[Uncommitted risk]]

imported>Doug Williamson: Create the page. Source: MCT reading 4.1.3, p12, 01 March 2012.

2015-05-19T08:16:17Z

Create the page. Source: MCT reading 4.1.3, p12, 01 March 2012.

New page

Non-transferable risks are risks which must be borne by an organisation.

Non-transferable risks might be avoided or accepted and retained or reduced as appropriate. In the case of non-transferable business risks (which by definition are not avoided) it is important that the firm has a distinctive competence in the relevant areas.

For example, a pharmaceutical company's non-transferable risks would include the risk that failure to gain approval for use of a new drug means that the research and development costs have been wasted.

== See also ==
*[[Transferable risk]]